{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:53:16Z","timestamp":1787500396882,"version":"build-2736575974"},"reference-count":90,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["945393"],"award-info":[{"award-number":["945393"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HemaSphere"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite its great promise, implementation of CAR\u2010T therapy\u2014a personalized, logistically complex, and expensive treatment\u2014remains challenging, hampering patient access across and within countries. Since 2018, six products have been centrally approved in Europe (i.e., the European Economic Area; EU\u2010approved) for 15 hematologic malignancy indications. To better understand patient access to EU\u2010approved commercial CAR\u2010T therapy, we evaluated the current status in all 30 countries where EU\u2010approval is valid plus the UK, addressing economic, clinical, and organizational aspects, and identifying challenges and strategies for improvement. A two\u2010step approach was used, complementing data from marketing authorization holders (4\/4 responded) with country\u2010specific insights from clinical experts obtained via an online survey (30\/31 responded). In August 2024, 26% of the 31 countries had no CAR\u2010T products commercially available, 74%\u2009\u2265\u20091 product for non\u2010Hodgkin lymphoma and leukemia, and 16%\u2009\u2265\u20091 product for multiple myeloma. One\u2010time payment was the most used reimbursement method. Time to access varied significantly, with medians ranging from 0 (France\/Germany) to 53 months (Slovakia). The median number of qualified CAR\u2010T centers per 10 million population per country was 5.0 (IQR: 3.0\u20136.1). In most countries, patient eligibility assessment was decentralized. Costs and logistical complexity were main factors restricting access in countries with and without commercially available products. Proposed solutions included cost reductions, improving reimbursement processes, and increasing healthcare resources. This study shows that patient access to commercial CAR\u2010T therapy in Europe remains limited. Its insights into this multi\u2010faceted problem can guide policy\u2010making, advocacy work, and research to make this transformative treatment accessible to more patients in need.<\/jats:p>","DOI":"10.1002\/hem3.70306","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:48:37Z","timestamp":1773010117000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The European CAR\u2010T map\u2014Current status and future directions to improve access to CAR T\u2010cell therapy for hematologic malignancies"],"prefix":"10.1002","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7674-2148","authenticated-orcid":false,"given":"Elise R. A.","family":"Pennings","sequence":"first","affiliation":[{"name":"Department of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The Netherlands"},{"name":"Cancer Center Amsterdam Amsterdam The Netherlands"},{"name":"LYMMCARE (Lymphoma and Myeloma Center Amsterdam) Amsterdam The Netherlands"},{"name":"Erasmus School of Health Policy and Management Erasmus University Rotterdam Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Thielen","sequence":"additional","affiliation":[{"name":"Erasmus School of Health Policy and Management Erasmus University Rotterdam Rotterdam The Netherlands"},{"name":"Erasmus Centre for Health Economics Rotterdam (EsCHER) Erasmus University Rotterdam Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Broussais","sequence":"additional","affiliation":[{"name":"Institut Carnot CALYM Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-4376","authenticated-orcid":false,"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[{"name":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) Barcelona Spain"},{"name":"Department of Hematology Hospital Clinic of Barcelona Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Jaeger","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Division of Hematology and Hemostaseology Medical University of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Sanges","sequence":"additional","affiliation":[{"name":"Lehrstuhl f\u00fcr Zellul\u00e4re Immuntherapie, Medizinische Klinik und Poliklinik II Universit\u00e4tsklinikum W\u00fcrzburg W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Cabrerizo","sequence":"additional","affiliation":[{"name":"European Hematology Association (EHA) The Hague The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutgart","family":"Roux\u2010Opstaele","sequence":"additional","affiliation":[{"name":"Institut National du Cancer (French National Cancer Institute INCa) Boulogne Billancourt  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dreuillet","sequence":"additional","affiliation":[{"name":"Institut National du Cancer (French National Cancer Institute INCa) Boulogne Billancourt  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eglys","family":"Gonzalez\u2010Marcano","sequence":"additional","affiliation":[{"name":"Patvocates GmbH Riemerling Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mill\u00e1n","sequence":"additional","affiliation":[{"name":"Patvocates GmbH Riemerling Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Huber","sequence":"additional","affiliation":[{"name":"Lehrstuhl f\u00fcr Zellul\u00e4re Immuntherapie, Medizinische Klinik und Poliklinik II Universit\u00e4tsklinikum W\u00fcrzburg W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Clavreul","sequence":"additional","affiliation":[{"name":"Myeloma Patients Europe Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Bola\u00f1os","sequence":"additional","affiliation":[{"name":"Lymphoma Coalition Europe Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Nier","sequence":"additional","affiliation":[{"name":"Acute Leukemia Advocates Network Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Mih\u00e1lyov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Hematooncology, Faculty Hospital Ostrava and Faculty of Medicine University of Ostrava Ostrava Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"H\u00e1jek","sequence":"additional","affiliation":[{"name":"Department of Hematooncology, Faculty Hospital Ostrava and Faculty of Medicine University of Ostrava Ostrava Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Hor\u0148\u00e1kov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Hematooncology, Faculty Hospital Ostrava and Faculty of Medicine University of Ostrava Ostrava Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Doeswijk","sequence":"additional","affiliation":[{"name":"European Hematology Association (EHA) The Hague The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9mato\u2010Oncologie, Assistance Publique\u2010H\u00f4pitaux de Paris, H\u00f4pital Saint\u2010Louis Universit\u00e9 Paris Cit\u00e9 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hudecek","sequence":"additional","affiliation":[{"name":"Lehrstuhl f\u00fcr Zellul\u00e4re Immuntherapie, Medizinische Klinik und Poliklinik II Universit\u00e4tsklinikum W\u00fcrzburg W\u00fcrzburg Germany"},{"name":"National Center for Tumor Diseases (NCT) WERA W\u00fcrzburg Germany"},{"name":"Bavarian Center for Cancer Research (BZKF) W\u00fcrzburg Germany"},{"name":"Fraunhofer Institute for Cell Therapy and Immunology (IZI) Division of Cellular Immunotherapy W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin A.","family":"Uyl\u2010de Groot","sequence":"additional","affiliation":[{"name":"Erasmus School of Health Policy and Management Erasmus University Rotterdam Rotterdam The Netherlands"},{"name":"Erasmus Centre for Health Economics Rotterdam (EsCHER) Erasmus University Rotterdam Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8904-3802","authenticated-orcid":false,"given":"Marie Jos\u00e9","family":"Kersten","sequence":"additional","affiliation":[{"name":"Department of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The Netherlands"},{"name":"Cancer Center Amsterdam Amsterdam The Netherlands"},{"name":"LYMMCARE (Lymphoma and Myeloma Center Amsterdam) Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1706169"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00754-1"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3200"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19751"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14100"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06243-w"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00226-5"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01622-0"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00591-X"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02986-9"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301665"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018730"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01222-8"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024850"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00933-8"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213614"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303379"},{"key":"e_1_2_11_25_1","unstructured":"European Medicines Agency.Yescarta \u2010 axicabtagene ciloleucel. Accessed August 11 2025.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/yescarta"},{"key":"e_1_2_11_26_1","unstructured":"European Medicines Agency. Kymriah \u2010 tisagenlecleucel. Accessed August 11 2025.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kymriah"},{"key":"e_1_2_11_27_1","unstructured":"European Medicines Agency.Breyanzi \u2010 lisocabtagene maraleucel. Accessed August 11 2025.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/breyanzi"},{"key":"e_1_2_11_28_1","unstructured":"European Medicines Agency. Tecartus brexucabtagene autoleucel. Accessed August 11 2025.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tecartus"},{"key":"e_1_2_11_29_1","unstructured":"European Medicines Agency. Abecma \u2010 idecabtagene vicleucel. Accessed August 11 2025.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/abecma"},{"key":"e_1_2_11_30_1","unstructured":"European Medicines Agency.Carvykti \u2010 ciltacabtagene autoleucel. Accessed August 11 2025.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/carvykti"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000524"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkae059"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2024.105153"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_397912"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2020.1715536"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2022-0037"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-021-00311-0"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1199500"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.04.011"},{"key":"e_1_2_11_40_1","unstructured":"IQVIA Institute for Human Data Science.Achieving CAR T\u2010cell therapy Health System Readiness: An Assessment of Barriers and Opportunities. Accessed August 11 2025.www.iqviainstitute.org"},{"key":"e_1_2_11_41_1","doi-asserted-by":"crossref","unstructured":"Kr\u00f6gerN GribbenJ ChabannonC Yakoub\u2010AghaI EinseleH. The EBMT\/EHA CAR\u2010T Cell Handbook.2022.","DOI":"10.1007\/978-3-030-94353-0"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-02072-7"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174334"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18209"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.915342"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1128295"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020578"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.04.003"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014171"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1397613"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020703"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00170-4"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01933"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00501"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.03.223"},{"key":"e_1_2_11_56_1","unstructured":"United Nations Department of Economic and Social Affairs.Population Division World Population Prospects 2024: Online Edition;2024."},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.3112"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70207"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70204"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3065"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2018.1511679"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05766-0"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0956-8"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.04.004"},{"key":"e_1_2_11_65_1","unstructured":"European Parliament and the Council of the European Union.Regulation (EU) 2021\/2282 of the European parliament and of the council of 15 December 2021 on health technology assessment and amending directive 2011\/24\/EU (Text with EEA relevance).Official J Eur Union.2021."},{"key":"e_1_2_11_66_1","unstructured":"ASCERTAIN.ASCERTAIN\u2014Affordability and Sustainability improvements through new pricing Cost\u2010Effectiveness andReimbursemenT models to Appraise INnovative health technologies. Accessed August 11 2025.https:\/\/www.access2meds.eu"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.3390\/jmahp12030012"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082313"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-022-00859-w"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2024.2393566"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101136"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.04.008"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.04.017"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.02.007"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02459-0"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2025.2513003"},{"key":"#cr-split#-e_1_2_11_77_1.1","unstructured":"European Commission.Regulation (EC) No 1394\/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001\/83\/EC and Regulation (EC) No 726\/2004 (Text with EEA relevance)"},{"key":"#cr-split#-e_1_2_11_77_1.2","unstructured":"2019. Accessed August 11 2025.http:\/\/data.europa.eu\/eli\/reg\/2007\/1394\/oj"},{"key":"e_1_2_11_78_1","unstructured":"European Commission European Health and Digital Executive Agency Rod\u00e9s S\u00e1nchezM GriepinkM Van der FeenJF Cuartas\u2010AcostaA et al.Study on the hospital exemption \u2013 Final report: Publications Office of the European Union;2025."},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2021.168"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.05.018"},{"key":"e_1_2_11_81_1","unstructured":"European Commission. Proposal for a Regulation of the European Parliament and of the Council laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency amending Regulation (EC) No 1394\/2007 and Regulation (EU) No 536\/2014 and repealing Regulation (EC) No 726\/2004 Regulation (EC) No 141\/2000 and Regulation (EC) No 1901\/2006: European Commission; 2023.https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex:52023PC0193"},{"key":"e_1_2_11_82_1","unstructured":"European Commission.Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use and repealing Directive 2001\/83\/EC and Directive 2009\/35\/EC: European Commission;2023.https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A52023PC0192."},{"key":"e_1_2_11_83_1","unstructured":"European Medicines Agency.Requesting scientific advice or protocol assistance from EMA 2025. Accessed September 19 2025.https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/scientific-advice-protocol-assistance\/requesting-scientific-advice-or-protocol-assistance-ema"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2025.103515"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.2025.v115i5.3070"},{"issue":"1","key":"e_1_2_11_86_1","first-page":"10","article-title":"Challenges in global access to CAR\u2010T cells: an Asian perspective","volume":"7","author":"Hwang WY","year":"2024","journal-title":"Blood Cell Therapy"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2025.100995"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06400-x"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009349"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.28877"}],"container-title":["HemaSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hem3.70306","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hem3.70306","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hem3.70306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T19:54:06Z","timestamp":1774814046000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hem3.70306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1002\/hem3.70306"],"URL":"https:\/\/doi.org\/10.1002\/hem3.70306","archive":["Portico"],"relation":{},"ISSN":["2572-9241","2572-9241"],"issn-type":[{"value":"2572-9241","type":"print"},{"value":"2572-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70306"}}